Duriez C, Falette N, Cortes U, Moyret-Lalle C, Puisieux A
Département d'Oncologie Fondamentale et Appliquée, INSERM Unité 453. Centre Léon Bérard, 28 rue Laënnec, 69008, Lyon, France.
Oncogene. 2000 May 11;19(20):2461-4. doi: 10.1038/sj.onc.1203580.
The p53 tumor suppressor protein functions to monitor the integrity of the genome. If a damage is detected, p53 binds tightly to specific sequence elements in the DNA and induces the transactivation of genes involved in various growth regulatory processes such as cell cycle progression, DNA repair and apoptosis. A p53-binding site was recently identified in the promoter region of the metastatic suppressor KAI1 gene, suggesting that this gene was a direct transcriptional target of p53. To test the relevance of this hypothesis, we studied the endogenous KAI1 expression in a series of human cell lines with varying p53 status in response to genotoxic treatment as well as in different cellular models exhibiting an inducible p53 activity. Overall, our data indicate that KAI1 expression is not significantly modulated by p53. This observation provides a direct evidence that the presence of a p53-binding site in regulatory domains is not a sufficient criteria to define a p53-transcriptional target gene.
p53肿瘤抑制蛋白的功能是监测基因组的完整性。如果检测到损伤,p53会紧密结合到DNA中的特定序列元件上,并诱导参与各种生长调节过程(如细胞周期进程、DNA修复和细胞凋亡)的基因的反式激活。最近在转移抑制基因KAI1的启动子区域发现了一个p53结合位点,这表明该基因是p53的直接转录靶点。为了验证这一假设的相关性,我们研究了一系列p53状态不同的人类细胞系在受到基因毒性处理后内源性KAI1的表达情况,以及在不同的具有可诱导p53活性的细胞模型中的表达情况。总体而言,我们的数据表明KAI1的表达不受p53的显著调节。这一观察结果提供了直接证据,即调控域中存在p53结合位点并不是定义p53转录靶基因的充分标准。